how to compound semaglutide FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products Risks of Compounding Semaglutide
Description
Patient safety considerations : GLP-1 medications carry potential adverse effects including nausea, vomiting, diarrhoea, constipation, and rarely, pancreatitis or gallbladder disease
To learn more and potentially get an Rx if appropriate for you, consult a healthcare provider either in person or virtually
Source: Cell Press Some people taking GLP-1 drugs for diabetes and obesity experience mental health benefitsparticularly, a decrease in symptoms of depression
Diabetes Obes Metab 24(1):160165
New studies and clinical trials come out regularly
